Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study
Al Sulaiman, Khalid, Korayem, Ghazwa B, Altebainawi, Ali F, Al Harbi, Shmeylan, Alissa, Abdulrahman, Alharthi, Abdullah, Kensara, Raed, Alfahed, Amjaad, Vishwakarma, Ramesh, Al Haji, Hussain, Almohaimid, Naif, Al Zumai, Omar, Alrubayan, Fahad, Asiri, Abdulmajid, Alkahtani, Nasser, Alolayan, Abdulaziz, Alsohimi, Samiah, Melibari, Nawal, Almagthali, Alaa, Aljahdali, Seba, Alenazi, Abeer A, Alsaeedi, Alawi S, Al Ghamdi, Ghassan, Al Faris, Omar, Alqahtani, Joud, Al Qahtani, Jalal, Alshammari, Khalid A, Alshammari, Khalil I, Aljuhani, Ohoud
Published in Critical care (London, England) (03.10.2022)
Published in Critical care (London, England) (03.10.2022)
Get full text
Journal Article